Logindo Samudramakmur Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Logindo Samudramakmur Tbk. trades at Rp101 (market cap 574.16B, 12.07M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,590 (market cap 11.36T, 1.77M 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 19.8× Logindo Samudramakmur Tbk.'s market cap, and Logindo Samudramakmur Tbk. is more actively traded (12.07M versus 1.77M). Which is the better fit depends on your goals.
| LEAD | TSPC | |
|---|---|---|
Market Cap | 574.16B | 11.36T |
Volume | 12.07M | 1.77M |
Lot | 120.69K | 17.71K |
Turnover | 1.2B | 4.61B |
Average Price | 99.77 | 2,603.9 |
Value | 1.2B | 4.61B |
Indicative Equilibrium Price | 101 | 2,590 |
Indicative Equilibrium Volume | 3.23K | 300 |
Trailing returns across standard periods
Latest headlines on both assets
PT Logindo Samudramakmur Tbk (the Company) is domiciled and was established in Jakarta, Indonesia based on Notarial Deed No. 55 of Nurul Hidajati Handoko, SH., Public Notary in Jakarta dated August 23, 1995. The company currently owns and operates a fleet of 58 offshore support with various types and functions. The company has a portfolio of customers ranging from mining oil and gas local to multinational.
Read more on LEAD →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →